Imagion Biosystems is pleased to provide an update on its capital management and progress towards its first-in-human study,
Read the Investor Update.
Imagion Biosystems receives AU$3.5 million in R&D tax incentives
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it